Severe hypertriglyceridaemia during therapy for childhood acute lymphoblastic leukaemia.
about
Non-infectious chemotherapy-associated acute toxicities during childhood acute lymphoblastic leukemia therapy.Protracted Administration of L-Asparaginase in Maintenance Phase Is the Risk Factor for Hyperglycemia in Older Patients with Pediatric Acute Lymphoblastic Leukemia.Asparaginase Potentiates Glucocorticoid-Induced Osteonecrosis in a Mouse ModelA retrospective analysis of treatment-related hospitalization costs of pediatric, adolescent, and young adult acute lymphoblastic leukemiaAsparaginase-associated toxicity in children with acute lymphoblastic leukemia.PEG-asparaginase induced severe hypertriglyceridemia.Design and Characterization of Erwinia Chrysanthemi l-Asparaginase Variants with Diminished l-Glutaminase ActivityHypertriglyceridemia during asparaginase treatment in children with acute lymphoblastic leukemia correlates with antithrombin activity in adolescents.Development of Metabolic Syndrome Associated to Cancer Therapy: Review.Incidence, risk factors, and treatment outcome of symptomatic osteonecrosis in Taiwanese children with acute lymphoblastic leukemia: a retrospective cohort study of 245 patients in a single institution.Adverse effects of pegaspargase in pediatric patients receiving doses greater than 3,750 IU.Asparaginase-associated pancreatitis is not predicted by hypertriglyceridemia or pancreatic enzyme levels in children with acute lymphoblastic leukemia.Hyperlipidemia is a risk factor for osteonecrosis in children and young adults with acute lymphoblastic leukemia.Bilateral corticosteroid-induced osteonecrosis of the femoral head detected at a 6-week interval.Severe hypertriglyceridemia during treatment of acute lymphoblastic leukemia associated with type III hyperlipoproteinemia.Correspondence: Osteonecrosis in childhood acute lymphoblastic leukemia: a retrospective cohort study of the Italian Association of Pediatric Haemato-Oncology (AIEOP)
P2860
Q33557148-B6EAAEA7-14C1-44A2-85EE-3AA0E086A127Q35758669-E39BDEB0-D4A1-44AB-A50F-015F7A842913Q35954058-2C3B5DA1-54A4-4B9A-963F-692550B79612Q36528384-41546CAC-2829-4DC0-9669-3FB016F91EA4Q36762608-96C5F017-388F-460D-BEBB-B3541A478219Q38578836-61827AA7-EFCE-42DA-8955-65E0A507894DQ38761096-CB9A0478-B737-4F82-94BC-1CA40A736A96Q38821455-5CF3B7CA-0E72-4358-9406-18D90A72E261Q38972507-CAA8164D-1862-43B4-A05A-7BD2BB4C91B7Q39021828-B8365398-C069-49D3-9A37-AB9B3E7F4D96Q39258365-29E29B17-8409-4DCE-A8C8-9E0CC7F5CC7DQ40609832-47CBC1B1-DAA0-4CD4-95E4-580577913FEDQ42336342-E6CF8E4A-0E00-400B-9F30-47095F36E1F8Q43192054-93A08610-2A77-43B9-AE88-A7ED385B9172Q53961613-4B484B52-1453-41DD-AE84-DD14227CF2CBQ59136673-FE89D7AA-1AEC-43A6-A10B-AEBE3C6B8293
P2860
Severe hypertriglyceridaemia during therapy for childhood acute lymphoblastic leukaemia.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Severe hypertriglyceridaemia during therapy for childhood acute lymphoblastic leukaemia.
@ast
Severe hypertriglyceridaemia during therapy for childhood acute lymphoblastic leukaemia.
@en
Severe hypertriglyceridaemia during therapy for childhood acute lymphoblastic leukaemia.
@nl
type
label
Severe hypertriglyceridaemia during therapy for childhood acute lymphoblastic leukaemia.
@ast
Severe hypertriglyceridaemia during therapy for childhood acute lymphoblastic leukaemia.
@en
Severe hypertriglyceridaemia during therapy for childhood acute lymphoblastic leukaemia.
@nl
prefLabel
Severe hypertriglyceridaemia during therapy for childhood acute lymphoblastic leukaemia.
@ast
Severe hypertriglyceridaemia during therapy for childhood acute lymphoblastic leukaemia.
@en
Severe hypertriglyceridaemia during therapy for childhood acute lymphoblastic leukaemia.
@nl
P2093
P2860
P50
P1476
Severe hypertriglyceridaemia during therapy for childhood acute lymphoblastic leukaemia.
@en
P2093
Cheng Cheng
Deqing Pei
John T Sandlund
Mary V Relling
Monika L Metzger
Rashid Darbandi
Wassim Chemaitilly
P2860
P304
P356
10.1016/J.EJCA.2014.06.023
P577
2014-07-30T00:00:00Z